BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Desbois M, Wang Y. Cancer-associated fibroblasts: Key players in shaping the tumor immune microenvironment. Immunol Rev 2021;302:241-58. [PMID: 34075584 DOI: 10.1111/imr.12982] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Li JJ, Tsang JY, Tse GM. Tumor Microenvironment in Breast Cancer-Updates on Therapeutic Implications and Pathologic Assessment. Cancers (Basel) 2021;13:4233. [PMID: 34439387 DOI: 10.3390/cancers13164233] [Reference Citation Analysis]
2 Wang J, Rieder F. A single-cell atlas of fibroblasts: one size does not fit all. Nat Rev Gastroenterol Hepatol 2021;18:595-6. [PMID: 34168369 DOI: 10.1038/s41575-021-00482-w] [Reference Citation Analysis]
3 Aghanejad A, Bonab SF, Sepehri M, Haghighi FS, Tarighatnia A, Kreiter C, Nader ND, Tohidkia MR. A review on targeting tumor microenvironment: The main paradigm shift in the mAb-based immunotherapy of solid tumors. Int J Biol Macromol 2022;207:592-610. [PMID: 35296439 DOI: 10.1016/j.ijbiomac.2022.03.057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kong W, Liu Z, Sun M, Liu H, Kong C, Ma J, Wang R, Qian F. Synergistic autophagy blockade and VDR signaling activation enhance stellate cell reprogramming in pancreatic ductal adenocarcinoma. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.215718] [Reference Citation Analysis]
5 Niu D, Wu Y, Lei Z, Zhang M, Xie Z, Tang S. Lactic acid, a driver of tumor-stroma interactions. International Immunopharmacology 2022;106:108597. [DOI: 10.1016/j.intimp.2022.108597] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Hao N, Zhou Y, Li Y, Zhang H, Wang B, Liu X, Ren Y, He J, Zhou C, Tang X. Clinical Value and Potential Mechanisms of Oxysterol-Binding Protein Like 3 (OSBPL3) in Human Tumors. Front Mol Biosci 2021;8:739978. [PMID: 34738015 DOI: 10.3389/fmolb.2021.739978] [Reference Citation Analysis]
7 Tian L, Long F, Hao Y, Li B, Li Y, Tang Y, Li J, Zhao Q, Chen J, Liu M. A Cancer Associated Fibroblasts-Related Six-Gene Panel for Anti-PD-1 Therapy in Melanoma Driven by Weighted Correlation Network Analysis and Supervised Machine Learning. Front Med 2022;9:880326. [DOI: 10.3389/fmed.2022.880326] [Reference Citation Analysis]
8 Zhang J, Zhang N, Fu X, Wang W, Liu H, McKay MJ, Dejkriengkraikul P, Nie Y. Bioinformatic analysis of cancer-associated fibroblast related gene signature as a predictive model in clinical outcomes and immune characteristics of gastric cancer. Ann Transl Med 2022;10:698. [PMID: 35845527 DOI: 10.21037/atm-22-2810] [Reference Citation Analysis]
9 Lu S, Hua J, Xu J, Wei M, Liang C, Meng Q, Liu J, Zhang B, Wang W, Yu X, Shi S. Turning towards nonimmunoreactive tumors: Evaluation of cancer-associated fibroblasts enables prediction of the immune microenvironment and treatment sensitivity in pancreatic cancer. Computational and Structural Biotechnology Journal 2022;20:3911-23. [DOI: 10.1016/j.csbj.2022.07.029] [Reference Citation Analysis]
10 Lin X, Xiao M, Chen Z, Ding C, Zhang T, Li Q, Xu Y. Pancancer Analyses Reveal Genomics and Clinical Characteristics of the SETDB1 in Human Tumors. Journal of Oncology 2022;2022:1-40. [DOI: 10.1155/2022/6115878] [Reference Citation Analysis]
11 Liu Y, Zhou X, Wang X. Targeting the tumor microenvironment in B-cell lymphoma: challenges and opportunities. J Hematol Oncol 2021;14:125. [PMID: 34404434 DOI: 10.1186/s13045-021-01134-x] [Reference Citation Analysis]
12 Fletcher AL, Turley SJ. Who am I? (re-)Defining fibroblast identity and immunological function in the age of bioinformatics. Immunol Rev 2021;302:5-9. [PMID: 34219244 DOI: 10.1111/imr.12993] [Reference Citation Analysis]
13 Yuan C, Zhang J, Deng C, Xia Y, Li B, Meng S, Jin X, Cheng L, Li H, Zhang C, He Y. Crosstalk of Histone and RNA Modifications Identified a Stromal-Activated Subtype with Poor Survival and Resistance to Immunotherapy in Gastric Cancer. Front Pharmacol 2022;13:868830. [DOI: 10.3389/fphar.2022.868830] [Reference Citation Analysis]
14 Qiu L, Yue J, Ding L, Yin Z, Zhang K, Zhang H. Cancer-associated fibroblasts: An emerging target against esophageal squamous cell carcinoma. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.215860] [Reference Citation Analysis]
15 Zhang M, Chen Z, Wang Y, Zhao H, Du Y. The Role of Cancer-Associated Fibroblasts in Ovarian Cancer. Cancers 2022;14:2637. [DOI: 10.3390/cancers14112637] [Reference Citation Analysis]
16 Fuller AM, Eisinger-mathason TSK. Context Matters: Response Heterogeneity to Collagen-Targeting Approaches in Desmoplastic Cancers. Cancers 2022;14:3132. [DOI: 10.3390/cancers14133132] [Reference Citation Analysis]